环丙沙星和头孢噻肟助推医院污水中耐药菌繁殖
Ciprofloxacin and cefotaxime help resistant bacteria thrive in hospital sewage
瑞典哥德堡大学团队发表于 Nature Communications 的研究显示,瑞典8个城市10家医院的污水均促进耐药菌富集,而对应的市政污水处理厂未见类似效应。研究者让敏感大肠杆菌对氟喹诺酮类和青霉素类耐药后可在医院污水中生长,据此锁定环丙沙星和头孢噻肟为主要驱动药物,医院下水道生物膜中也观察到耐药大肠杆菌富集。研究团队认为这提示医院污水系统应作为针对性干预的重点。
研究在瑞典10家医院下水道中直接观察到耐药菌富集,为把医院污水列为干预重点提供了现场证据。
Antibiotics excreted by patients promote antibiotic-resistant bacteria in hospital sewers, according to a new study by researchers at the University of Gothenburg, Sweden. Ultimately, this may contribute to the development and spread of hard-to-treat infections. Pinpointing the responsible antibiotics paves the way for targeted measures.
"To the best of my knowledge, this is the first direct field evidence in over 25 years conclusively linking observed environmental effects to pharmaceuticals excreted from humans," says Joakim Larsson, professor of environmental pharmacology at the University of Gothenburg in Sweden.
Hospital sewers emerge as intervention targets
The study, published in Nature Communications, examined sewer systems and wastewater from hospitals and municipal treatment plants in eight Swedish cities. Sewage from all 10 hospitals promoted antibiotic-resistant bacteria, while no such effects were found after exposure to sewage from the corresponding municipal treatment plants.
International guidelines emphasize the need to limit selection for antibiotic resistance in the environment, as antibiotic pollution could ultimately render antibiotics ineffective. The observation of strong resistance selection in hospital sewer systems, but not in municipal ones, is significant for where measures should be prioritized.
While advanced treatment at municipal sites can reduce the further spread of antibiotics and other pharmaceuticals, it cannot prevent the resistance evolution that has already taken place in hospital sewage. The results therefore point to hospital sewage systems as a critical site for future targeted interventions.
"Knowing where resistant bacteria are promoted—and where they are less likely to be—is crucial when deciding how resources and efforts should be allocated to limit risks for antibiotic resistance development," says Larsson.
Two antibiotic classes drive resistance
When the researchers made a sensitive E. coli strain resistant to fluoroquinolones and penicillin-like antibiotics, it was able to grow well in hospital sewage where it otherwise could not. This showed that it was primarily these antibiotic classes that were responsible for giving resistant bacteria an advantage.
Ciprofloxacin was identified as a key driver, a commonly used antibiotic in the fluoroquinolone group often prescribed for urinary tract infections. Cefotaxime, a penicillin-like antibiotic only used in hospitals, also contributed. Several independent lines of evidence, including chemical analyses and studies of bacterial cell responses, pointed in the same direction.
"The findings suggest that similar resistance selection occurs in the sewers of most hospitals worldwide. In Sweden, total antibiotic use is relatively low, but hospital use is comparable to that in many other European countries," explains Larsson.
"Antibiotic use must always be guided by patients' medical needs," he continues. "But now that we know which types of drugs drive resistance selection in sewage, we can also develop more targeted solutions to mitigate risks." The research team is currently working to develop a simple, targeted treatment method to reduce the selection pressure in the sewers.
Direct evidence from sewer biofilms
Most conclusions about the environmental effects of pharmaceuticals are based on experiments where researchers intentionally add drugs at concentrations matching those measured in the environment. Such studies show what effects drugs can cause, but not whether those effects actually occur under real-world environmental conditions.
The current study goes one step further by documenting effects directly within hospital sewer pipes. Resistant E. coli were enriched in biofilms in hospital sewers compared with the wastewater, whereas no corresponding enrichment was observed at municipal treatment plants.
The last clear field evidence of a similar nature dates back to the late 1990s, when feminization of fish downstream of treatment plants was linked to pharmaceuticals from human use. Then, as now, Larsson contributed to identifying the substance responsible, in that case the contraceptive hormone ethinylestradiol.
Publication details
Declan A. Gray et al., Widespread selection of antibiotic resistance within hospital sewers, Nature Communications (2026). DOI: 10.1038/s41467-026-78836-8
Journal information: Nature Communications
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Ciprofloxacin and cefotaxime help resistant bacteria thrive in hospital sewage (2026, October 29) retrieved 29 October 2026 from https://medicalxpress.com/news/2026-10-ciprofloxacin-cefotaxime-resistant-bacteria-hospital.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com